Early research (Phase 1)Study completedNCT00304460
What this trial is testing
Mechanism of Action of High-Dose IL-2 (Aldesleukin) in Metastatic Melanoma and Kidney Cancer
Who this might be right for
Metastatic MelanomaRenal Cell Cancer
National Cancer Institute (NCI) 138